BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4835505)

  • 1. Pancreatic hypoperfusion and the production of a myocardial depressant factor in hemorrhagic shock.
    Lefer AM; Spath JA
    Ann Surg; 1974 Jun; 179(6):868-76. PubMed ID: 4835505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effect of anisodamine in hemorrhagic shock.
    Su J; Hock CE; Lefer AM
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):360-5. PubMed ID: 6728045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of arachidonic acid during hemorrhagic shock in the dog.
    Flynn JT; Lefer AM
    Circ Res; 1977 Apr; 40(4):422-8. PubMed ID: 844155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the pancreas in the pathogenesis of circulatory shock.
    Lefer AM; Glenn TM
    Adv Exp Med Biol; 1971 Oct; 23(0):311-35. PubMed ID: 5006110
    [No Abstract]   [Full Text] [Related]  

  • 5. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.
    Bitterman H; Yanagisawa A; Lefer AM
    Circ Shock; 1986; 20(1):1-11. PubMed ID: 2945667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of AVP in maintenance of circulatory homeostasis during hemorrhagic shock.
    Hock CE; Su JY; Lefer AM
    Am J Physiol; 1984 Feb; 246(2 Pt 2):H174-9. PubMed ID: 6696129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mechanism of action of a prostacyclin enhancing agent in haemorrhagic shock.
    Bitterman H; Lefer DJ; Lefer AM
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):679-86. PubMed ID: 3063971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salutary effects of nitrendipine, a new calcium entry blocker, in hemorrhagic shock.
    Hock CE; Su JY; Lefer AM
    Eur J Pharmacol; 1984 Jan; 97(1-2):37-46. PubMed ID: 6698110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic perfusion in the pathophysiology of hemorrhagic shock.
    Spath JA; Gorczynski RJ; Lefer AM
    Am J Physiol; 1974 Feb; 226(2):443-51. PubMed ID: 4811203
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence for a role of platelet activating factor in hypovolemic shock in the rat.
    Zingarelli B; Squadrito F; Bussolino F; Calapai G; Altavilla D; Ioculano M; Campo GM; Canale P; Caputi AP
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):123-34. PubMed ID: 8012759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of cellular integrity as a protective mechanism of dexamethasone in hemorrhagic shock in the cat.
    Trachte GJ; Lefer AM
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):309-20. PubMed ID: 677964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of suppression of endocrine or exocrine pancreatic function in hemorrhagic shock.
    Galvin MJ; Lefer AM
    Experientia; 1979 Jan; 35(1):55-6. PubMed ID: 369876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salutary effects of CG-4203, a novel, stable prostacyclin analog, in hemorrhagic shock.
    Bitterman H; Smith BA; Lefer DJ; Lefer AM
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):293-9. PubMed ID: 2464101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of thyrotropin releasing hormone (TRH) in circulatory shock.
    Hock CE; Lefer AM
    Peptides; 1985; 6(3):547-53. PubMed ID: 3934648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Myocardial depressant factor (MDF) in cardiogenic shock.
    Vaisrub S
    JAMA; 1974 Apr; 228(4):500. PubMed ID: 4406217
    [No Abstract]   [Full Text] [Related]  

  • 16. The pathophysiologic role of myocardial depressant factor as a mediator of circulatory shock.
    Lefer AM
    Klin Wochenschr; 1982 Jul; 60(14):713-6. PubMed ID: 6181287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of hypertonic saline in the treatment of hemorrhagic shock.
    Bitterman H; Triolo J; Lefer AM
    Circ Shock; 1987; 21(4):271-83. PubMed ID: 3581442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on a pancreatic cardiodepressant factor.
    Sagher U; Rosen H; Sarel O; Becker Y
    Circ Shock; 1986; 19(3):319-27. PubMed ID: 3731406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial performance during hemorrhagic shock in the pancreatectomized dog.
    Coleman B; Kallal JE; Feigen LP; Glaviano VV
    Am J Physiol; 1975 May; 228(5):1462-8. PubMed ID: 1130549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salutary consequences of blockade of platelet activating factor in hemorrhagic shock.
    Stahl GL; Bitterman H; Terashita Z; Lefer AM
    Eur J Pharmacol; 1988 May; 149(3):233-40. PubMed ID: 3409951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.